Asan Multivessel Registry

N/ARecruitingNCT02039752

Seung-Jung Park25,000 enrolled

Overview

The purpose of this study is to evaluate long-term prognoses of patients with multivessel coronary disease treated medically or surgically or percutaneously in real world practice.

Study Type

OBSERVATIONAL

Enrollment

25,000

Conditions

Coronary Artery Disease

Interventions

TreatmentOTHER

Eligibility

Sex: ALLMin age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with multivessel disease from 1995 in Asan Medical Center * Age 19 and more Exclusion Criteria: * For prospective cohort, not agreeing to participate with written informed consent form

Locations (1)

Asan Medical Center

Seoul, South Korea

RECRUITING

Outcomes

Primary Outcomes

composite event

death, myocardial infarction, stroke, revascularization

Time frame: 1year

Secondary Outcomes

Death

Time frame: 1year

Myocardial Infarction

Time frame: 1year

Stroke

Time frame: 1year

Revascularization

Time frame: 1year

Angina symptom

Time frame: 1year

Bleeding

Time frame: 1year

Re-hospitalization

Time frame: 1year

Stent thrombosis

by ARC(Academic Research Consortium) category

Time frame: 1year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.